8th Annual USC Multidisciplinary Breast Cancer Symposium

 

8th Annual USC Multidisciplinary Breast Cancer Symposium
Avatar

2021 Updates on HER2+ MBC: Tucatinib Combo and HRQoL in Brain Mets, Margetuximab+Chemo vs. Tras+Chemo, Subcutaneous Formulations

By 8th Annual USC Multidisciplinary Breast Cancer Symposium FEATURING William Gradishar
By 8th Annual USC Multidisciplinary Breast Cancer Symposium FEATURING William Gradishar
121 views
February 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Videos
05:35

HR+HER2- High-Risk eBC: Surveying Efficacy Data of CDK4/6i in the Ad…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

193 views
09:19

HR+/HER2- MBC: Outcomes of 1/2L CDK4/6 Inhibition

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

272 views
09:50

ER+ Early Stage BC: Which Patients Should Avoid Chemotherapy? Does C…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

211 views
06:22

PI3K/AKT/mTOR Inhibition in Advanced BC: Is There Any Benefit With A…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

74 views
30:59

Genetic Risk in BC: BRCA1/2 Mutations, Genetic Testing, Preventive B…

8th Annual USC Multidisciplinary Breast Cancer Symposium

B. Arun

28 views
35:08

Oncoplastic Surgery and BC: What Is Extreme Oncoplasty? When Can We …

8th Annual USC Multidisciplinary Breast Cancer Symposium

M. Silverstein

58 views
28:38

Diagnostic MRI for Newly Diagnosed BC: Factors of Occult Lesions Det…

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Sener

480 views
39:07

2021 Challenges in HER2+ BC Testing: IHC Guidelines, Biomarker Testi…

8th Annual USC Multidisciplinary Breast Cancer Symposium

M. Press

60 views
18:27

2021 Updates on HER2+ MBC: What Does the New Data on T-DXd Suggest? …

8th Annual USC Multidisciplinary Breast Cancer Symposium

W. Gradishar

433 views
11:34

2021 Updates on HER2+ MBC: Tucatinib Combo and HRQoL in Brain Mets, …

8th Annual USC Multidisciplinary Breast Cancer Symposium

W. Gradishar

121 views
19:06

USC Update on 1L Chemo Combination for Advanced TNBC: Does the Addit…

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

145 views
06:31

Innovations in Management of mTNBC: PARP Inhibitors

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

366 views
13:11

Clinical Trial Data on ADCs in TNBC: Sacituzumab Govitecan Efficacy …

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

251 views